Sector: health
Conviction from: S&P
52-week range: 62.3894.16
Solventum, a healthcare spinoff from 3M, develops and sells medical, dental, wound-care, health-information and water-filtration products for hospitals and clinicians.
6 tracked filer(s) hold this · 1 opened, 1 added, 3 trimmed in 30-SEP-2026
Aggregate 13FScore 58 — mean of 6 scored holder(s) · buyers (new/add) avg 58. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Larry Robbins / Glenview | 61 | New buy | 2,400 | $211,560 | 0.0% |
| Bridgewater | 55 | Added +91% | 339,850 | $29,957,777 | 0.1% |
| Nelson Peltz / Trian | 53 | Holds (flat) | 8,236,753 | $726,069,777 | 28.0% |
| Ancora | 42 | Trimmed -8% | 676 | $59,589 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -90% | 11,890 | $1,048,103 | 0.0% |
| Steve Cohen / Point72 | 75 | Trimmed -94% | 6,300 | $555,345 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
3 disclosed trade(s) by 3 filer(s).
4 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-07-01 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,004 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |